Development of universal influenza vaccines based on influenza virus M and NP genes
- PMID: 24178189
- DOI: 10.1007/s15010-013-0546-4
Development of universal influenza vaccines based on influenza virus M and NP genes
Abstract
Purpose: Vaccination is the safest and most effective measure against influenza virus infections. However, traditional influenza vaccines cannot respond effectively to an unforeseen epidemic or pandemic caused by a virus with antigenic drifts or antigenic shifts. Therefore, developing a universal influenza vaccine (UIV) that induces broad-spectrum and long-term immunity has become a major trend in influenza vaccine research and development.
Methods: This article reviews the development of UIVs based on these conserved influenza virus proteins.
Results and conclusion: The matrix protein (M1, M2) and nucleoprotein (NP) of influenza viruses have highly conserved sequences, and they become the major target antigens of current UIV studies.
Similar articles
-
Towards a universal vaccine for avian influenza: protective efficacy of modified Vaccinia virus Ankara and Adenovirus vaccines expressing conserved influenza antigens in chickens challenged with low pathogenic avian influenza virus.Vaccine. 2013 Jan 11;31(4):670-5. doi: 10.1016/j.vaccine.2012.11.047. Epub 2012 Nov 28. Vaccine. 2013. PMID: 23200938 Free PMC article.
-
Incorporation of conserved nucleoprotein into influenza virus-like particles could provoke a broad protective immune response in BALB/c mice and chickens.Virus Res. 2015 Jan 2;195:35-42. doi: 10.1016/j.virusres.2014.09.018. Virus Res. 2015. PMID: 25312452
-
Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge.Front Immunol. 2019 Aug 21;10:2005. doi: 10.3389/fimmu.2019.02005. eCollection 2019. Front Immunol. 2019. PMID: 31497029 Free PMC article.
-
Progress on adenovirus-vectored universal influenza vaccines.Hum Vaccin Immunother. 2015;11(5):1209-22. doi: 10.1080/21645515.2015.1016674. Hum Vaccin Immunother. 2015. PMID: 25876176 Free PMC article. Review.
-
Influenza A viruses: why focusing on M2e-based universal vaccines.Virus Genes. 2011 Feb;42(1):1-8. doi: 10.1007/s11262-010-0547-7. Epub 2010 Nov 17. Virus Genes. 2011. PMID: 21082230 Review.
Cited by
-
High-Yield Expression and Purification of Recombinant Influenza Virus Proteins from Stably-Transfected Mammalian Cell Lines.Vaccines (Basel). 2020 Aug 21;8(3):462. doi: 10.3390/vaccines8030462. Vaccines (Basel). 2020. PMID: 32825605 Free PMC article.
-
Virus replicon particle vaccines expressing nucleoprotein of influenza A virus mediate enhanced inflammatory responses in pigs.Sci Rep. 2017 Nov 27;7(1):16379. doi: 10.1038/s41598-017-16419-w. Sci Rep. 2017. PMID: 29180817 Free PMC article.
-
M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection.Mucosal Immunol. 2018 Jan;11(1):273-289. doi: 10.1038/mi.2017.14. Epub 2017 Mar 1. Mucosal Immunol. 2018. PMID: 28295019
-
Influenza Chimeric Protein (3M2e-3HA2-NP) Adjuvanted with PGA/Alum Confers Cross-Protection against Heterologous Influenza A Viruses.J Microbiol Biotechnol. 2021 Feb 28;31(2):304-316. doi: 10.4014/jmb.2011.11029. J Microbiol Biotechnol. 2021. PMID: 33263336 Free PMC article.
-
Protective Efficacy of the Conserved NP, PB1, and M1 Proteins as Immunogens in DNA- and Vaccinia Virus-Based Universal Influenza A Virus Vaccines in Mice.Clin Vaccine Immunol. 2015 Jun;22(6):618-30. doi: 10.1128/CVI.00091-15. Epub 2015 Apr 1. Clin Vaccine Immunol. 2015. PMID: 25834017 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous